Abstract:Introduction. Oxymatrine is a natural quinazine alkaloid extracted from Sophora flavescens and has many medicinal values. Oxymatrine showed protective effects, viral inhibition and effects against lung cancer.Hypothesis/Gap Statement. Individuals with lung cancer exhibit heightened vulnerability to COVID-19 infection due to compromised immune function. In conjunction with COVID-19, it is hypothesized that oxymatrine may exert potent pharmacological effects on lung cancer patients.Aim. The objective of this study was to assess the pharmacological mechanisms and targets of oxymatrine in relation to COVID-19 lung cancer.Methodology. Utilizing network pharmacology analysis, a selection of 2628 genes were identified as co-targets for both COVID-19 and lung cancer. Subsequently, a clinicopathological analysis was conducted by integrating RNA-Seq and clinical data obtained from the TCGA-LUAD lung cancer dataset, which was acquired from the official TCGA website. The identification of pharmacological targets for oxymatrine was accomplished through the utilization of various databases including Pharm mapper, SWISS Target prediction, and STITCH. These identified targets were further investigated for protein-protein interaction (PPI) using STRING, as well as for gene ontology (GO) and KEGG pathways.Results. The effects of oxymatrine on COVID-19-induced lung cancer were mediated by immune regulation, cytoprotection, antiviral, and anti-inflammatory activities, immune regulation, and control of related signalling pathways, including the formation of the neutrophil extracellular trap, phagosome, Toll-like receptor signalling pathway, apoptosis, proteoglycans in cancer, extracellular matrix disassembly, and proteolysis involved in cellular protein catabolism. Furthermore, important substances and genes like ALB, MMP3, MMP1, and TLR4 may affect how oxymatrine suppresses lung cancer/COVID-19 development.Conclusion. To treat COVID-19 or lung cancer paired with COVID-19, oxymatrine may improve the therapeutic efficacy of current clinical antiviral medicines and immunotherapy.

Study on Oxymatrine-Based Research from 2001 to 2022: A Bibliometric Analysis

Effects of Matrine and Oxymatrine on Catalytic Activity of Cytochrome P450s in Rats.

Study Progress of Oxymatrine about Its Anti Inflammatory Action

Oxymatrine and Cancer Therapy

Explore intersection genes of oxymatrine and COVID-19 with lung cancer as potential therapeutic targets based on network pharmacology

Antimitotic effects of the biopesticide oxymatrine

Research progress of matrine's anticancer activity and its molecular mechanism

Oxymatrine Promotes S-Phase Arrest and Inhibits Cell Proliferation of Human Breast Cancer Cells in Vitro Through Mitochondria-Mediated Apoptosis.

A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine

Research Advances on Matrine

Synthesis, characterization and in vitro biological evaluation of two matrine derivatives

Matrine: A Promising Natural Product With Various Pharmacological Activities

Toxic Markers of Matrine Determined Using (1) H-NMR-Based Metabolomics in Cultured Cells In Vitro and Rats In Vivo.

[Hotspots and trends of Ophiopogonis Radix based on CiteSpace knowledge map]

Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c

Anti-Inflammatory Effects of Oxymatrine Through Inhibition of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Activation in Lipopolysaccharide-Induced Bv2 Microglia Cells

Oxymatrine suppresses colorectal cancer progression by inhibiting NLRP3 inflammasome activation through mitophagy induction in vitro and in vivo

Biologically active isoquinoline alkaloids covering 2019–2022

Protective Effects of Oxymatrine Against Arsenic Trioxide-Induced Liver Injury

Oxymatrine Inhibits the Development of Non-Small Cell Lung Cancer Through Mir-367-3p Upregulation and Target Gene SGK3 Downregulation.

Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: a study on the anti-hepatitis B virus mechanism of oxymatrine